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ABSTRACT 
 
 
Background: Warfarin is the most commonly used oral anticoagulant and has a 
narrow therapeutic window therefore requires frequent monitoring to maintain the 
desired treatment targets. Time in therapeutic range (TTR) usually use to identify the 
quality of INR control in patient with oral anticoagulant. We examined the status  of 
and factor influence TTR and also bleeding and thromboembolic event in warfarin 
MTAC patients. Methods: We enrolled 162 patients from warfarin MTAC patients 
list. Patient‘s data were accessed retrospectively through electronic medical records. 
TTR was calculated using the linear interpolation technique. Descriptive data were 
analysed using frequency and percentage. Simple logistic regression was used for 
univariate analyses. Result: The mean of the individual‘s TTR calculated by using the 
Rosendaal method was 76%, (SD 18.5%) and only 24% of the INR value was out of 
the target range. Overall percentage of bleeding event would be 11.7% and percentage 
of thromboembolic events was only around 0.6%. Overall out of 162 patients, 135 
patients show the TTR value is more than 60% and only 27 patients the TTR value 
less than 60%.TTR was not affected by age, gender, sex, race, indications, duration of 
warfarin, weekly dose and number of concurrent medication. Missed dose was the 
only statistical significant predictor of poor TTR value (P < 0.001). In patient with 
missed dose of warfarin has a 2.2 times more likely of having TTR value less than 
60% with 95% confident interval (1.50 to 3.12). Conclusion: TTR is generally high in 
pharmacist managed clinic patients. The INR value most of time was spent within the 
target ranges. Thus, reflecting a good INR control in pharmacist managed clinic. 
Keywords: Anticoagulant, TTR, pharmacist-managed clinic 
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